These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA. Kumar P; Naimi E; McEwan AJ; Wiebe LI Bioorg Med Chem; 2010 Mar; 18(6):2255-2264. PubMed ID: 20181485 [TBL] [Abstract][Full Text] [Related]
12. Simple, column purification technique for the fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA). Nandy SK; Rajan MG Appl Radiat Isot; 2010 Oct; 68(10):1944-9. PubMed ID: 20478712 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108 [TBL] [Abstract][Full Text] [Related]
14. Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers. Bonnet M; Hong CR; Gu Y; Anderson RF; Wilson WR; Pruijn FB; Wang J; Hicks KO; Hay MP Bioorg Med Chem; 2014 Apr; 22(7):2123-32. PubMed ID: 24650701 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents]. Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[ Wanek T; Kreis K; Križková P; Schweifer A; Denk C; Stanek J; Mairinger S; Filip T; Sauberer M; Edelhofer P; Traxl A; Muchitsch VE; Mereiter K; Hammerschmidt F; Cass CE; Damaraju VL; Langer O; Kuntner C Bioorg Med Chem; 2016 Nov; 24(21):5326-5339. PubMed ID: 27614920 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with ¹⁸F-Fluoroazomycin Arabinoside and ¹⁵O-H₂O PET. Iqbal R; Kramer GM; Verwer EE; Huisman MC; de Langen AJ; Bahce I; van Velden FH; Windhorst AD; Lammertsma AA; Hoekstra OS; Boellaard R J Nucl Med; 2016 Apr; 57(4):530-5. PubMed ID: 26659349 [TBL] [Abstract][Full Text] [Related]
18. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients. Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography. Picchio M; Beck R; Haubner R; Seidl S; Machulla HJ; Johnson TD; Wester HJ; Reischl G; Schwaiger M; Piert M J Nucl Med; 2008 Apr; 49(4):597-605. PubMed ID: 18344437 [TBL] [Abstract][Full Text] [Related]